ABLIM2 | Actin binding LIM protein family, member 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
AC009133.22 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000404873} | Predicted secreted proteins
| | | | | Tissue enhanced |
AC069368.3 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000397942} | Predicted intracellular proteins
| | | | | Tissue enhanced |
AC092881.1 | HCG2014696 {ECO:0000313|EMBL:EAW97250.1}; PRO1454 {ECO:0000313|EMBL:AAG35485.1} | Predicted intracellular proteins
| | | | | Tissue enhanced |
AC141272.1 | | Predicted intracellular proteins
| | | | | Tissue enhanced |
AC233755.2 | | Predicted intracellular proteins
| | | | | Tissue enhanced |
ACAP1 | ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADCYAP1 | Adenylate cyclase activating polypeptide 1 (pituitary) | Predicted secreted proteins
| | | | | Tissue enhanced |
ADRA1B | Adrenoceptor alpha 1B | Cancer-related genes FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AFAP1L2 | Actin filament associated protein 1-like 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
AFF2 | AF4/FMR2 family, member 2 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
AIM2 | Absent in melanoma 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ALG1L2 | ALG1, chitobiosyldiphosphodolichol beta-mannosyltransferase-like 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
AMICA1 | Adhesion molecule, interacts with CXADR antigen 1 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ANKRD33B | Ankyrin repeat domain 33B | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANXA2R | Annexin A2 receptor | Predicted intracellular proteins
| | | | | Tissue enhanced |
AOAH | Acyloxyacyl hydrolase (neutrophil) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
APLNR | Apelin receptor | G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
APOBEC3A | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A | Predicted intracellular proteins
| | | | | Tissue enhanced |
APOBEC3B | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B | Predicted intracellular proteins
| | | | | Tissue enhanced |
AQP9 | Aquaporin 9 | Predicted membrane proteins
| | | | | Tissue enhanced |
ARG1 | Arginase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
ARHGAP11B | Rho GTPase activating protein 11B | Predicted intracellular proteins
| | | | | Tissue enhanced |
ARHGAP15 | Rho GTPase activating protein 15 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ARHGAP25 | Rho GTPase activating protein 25 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ARHGAP9 | Rho GTPase activating protein 9 | Predicted intracellular proteins
| | | | | Tissue enhanced |
ARL11 | ADP-ribosylation factor-like 11 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
ART4 | ADP-ribosyltransferase 4 (Dombrock blood group) | Blood group antigen proteins CD markers Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ASTL | Astacin-like metallo-endopeptidase (M12 family) | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
ATAD5 | ATPase family, AAA domain containing 5 | Predicted secreted proteins
| | | | | Tissue enhanced |
ATP8B4 | ATPase, class I, type 8B, member 4 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AURKB | Aurora kinase B | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
BACH2 | BTB and CNC homology 1, basic leucine zipper transcription factor 2 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
BATF | Basic leucine zipper transcription factor, ATF-like | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
BCAS4 | Breast carcinoma amplified sequence 4 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
BCL2A1 | BCL2-related protein A1 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
BIN2 | Bridging integrator 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
BRCA2 | Breast cancer 2, early onset | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
C10orf105 | Chromosome 10 open reading frame 105 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C11orf21 | Chromosome 11 open reading frame 21 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C12orf77 | Chromosome 12 open reading frame 77 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C16orf54 | Chromosome 16 open reading frame 54 | Predicted membrane proteins
| | | | | Tissue enhanced |
C17orf53 | Chromosome 17 open reading frame 53 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C19orf35 | Chromosome 19 open reading frame 35 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C19orf38 | Chromosome 19 open reading frame 38 | Predicted membrane proteins
| | | | | Tissue enhanced |
C2orf48 | Chromosome 2 open reading frame 48 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C3AR1 | Complement component 3a receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |